John A. Ward

Array ( [id] => 6429537 [patent_doc_number] => 20020127246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Use of herpes vectors for tumor therapy' [patent_app_type] => new [patent_app_number] => 10/079534 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9541 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127246.pdf [firstpage_image] =>[orig_patent_app_number] => 10079534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6819227 [patent_doc_number] => 20030070185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Transgenic mammals having human Ig loci including plural Vh and Vk regions and antibodies produced therefrom' [patent_app_type] => new [patent_app_number] => 10/078958 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 19892 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20030070185.pdf [firstpage_image] =>[orig_patent_app_number] => 10078958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545244 [patent_doc_number] => 20020137716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Bovine polynucleotide vaccine for the intradermal route' [patent_app_type] => new [patent_app_number] => 10/077489 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4541 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137716.pdf [firstpage_image] =>[orig_patent_app_number] => 10077489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778613 [patent_doc_number] => 20030049694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Production of fusion proteins and use for identifying binding molecules' [patent_app_type] => new [patent_app_number] => 10/077213 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6371 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049694.pdf [firstpage_image] =>[orig_patent_app_number] => 10077213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554215 [patent_doc_number] => 20020164313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Compositions comprising preconditioned myoblasts having enhanced fusion properties' [patent_app_type] => new [patent_app_number] => 10/058281 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11365 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164313.pdf [firstpage_image] =>[orig_patent_app_number] => 10058281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 852706 [patent_doc_number] => 07378087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Method of enhancing an immune response' [patent_app_type] => utility [patent_app_number] => 10/046542 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 42 [patent_no_of_words] => 29606 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378087.pdf [firstpage_image] =>[orig_patent_app_number] => 10046542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450156 [patent_doc_number] => 20020177547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Pharmaceutical compositions for treating or preventing cancer' [patent_app_type] => new [patent_app_number] => 10/047539 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11357 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177547.pdf [firstpage_image] =>[orig_patent_app_number] => 10047539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6862810 [patent_doc_number] => 20030093818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Transgenic animals comprising a humanized immune system' [patent_app_type] => new [patent_app_number] => 10/024648 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20393 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 81 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20030093818.pdf [firstpage_image] =>[orig_patent_app_number] => 10024648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721529 [patent_doc_number] => 20030055219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Protein-protein interactions' [patent_app_type] => new [patent_app_number] => 10/014799 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11218 [patent_no_of_claims] => 160 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055219.pdf [firstpage_image] =>[orig_patent_app_number] => 10014799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762158 [patent_doc_number] => 20030125520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Novel hemopoietin receptor protein, NR10' [patent_app_type] => new [patent_app_number] => 10/006265 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23154 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125520.pdf [firstpage_image] =>[orig_patent_app_number] => 10006265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720582 [patent_doc_number] => 07049426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions' [patent_app_type] => utility [patent_app_number] => 09/999321 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 31005 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049426.pdf [firstpage_image] =>[orig_patent_app_number] => 09999321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745671 [patent_doc_number] => 20030022854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Vaccines using nucleic acid-lipid complexes' [patent_app_type] => new [patent_app_number] => 10/012597 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20201 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022854.pdf [firstpage_image] =>[orig_patent_app_number] => 10012597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112628 [patent_doc_number] => 20020173477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'ANTI-IgE gene therapy' [patent_app_type] => new [patent_app_number] => 09/991470 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8179 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173477.pdf [firstpage_image] =>[orig_patent_app_number] => 09991470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843164 [patent_doc_number] => 20030148511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Induction of immunity using inhibitors of granzymes' [patent_app_type] => new [patent_app_number] => 09/993363 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32079 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148511.pdf [firstpage_image] =>[orig_patent_app_number] => 09993363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463647 [patent_doc_number] => 20040101513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Enhancement of immune response to vaccine by interferon alpha' [patent_app_type] => new [patent_app_number] => 10/416315 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9560 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101513.pdf [firstpage_image] =>[orig_patent_app_number] => 10416315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097861 [patent_doc_number] => 20050130320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Method for identifying the proteome of cells using an antibody library microarray' [patent_app_type] => utility [patent_app_number] => 10/416435 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10724 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130320.pdf [firstpage_image] =>[orig_patent_app_number] => 10416435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6305353 [patent_doc_number] => 20020094327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Targeting pluripotent stem cells to tissues' [patent_app_type] => new [patent_app_number] => 10/013015 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15374 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094327.pdf [firstpage_image] =>[orig_patent_app_number] => 10013015 [rel_patent_id] =>[rel_patent_doc_number] =>)